Home > Boards > US Listed > Biotechs > Lexicon Genetics (LXRX)

Shorts wanted to fill the gap is what

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BooDog Member Profile
 
Followed By 193
Posts 20,088
Boards Moderated 4
Alias Born 08/03/06
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/17/2020 7:23:07 AM
Results From SOLOIST and SCORED Outcomes Studies Presented at Late-Breaking Science Session of American Heart Association Sci... GlobeNewswire Inc. - 11/16/2020 10:01:39 PM
Lexicon Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare Conference GlobeNewswire Inc. - 11/16/2020 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/30/2020 5:11:39 PM
Lexicon Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical Update GlobeNewswire Inc. - 10/29/2020 6:00:10 AM
Lexicon Pharmaceuticals to Host Third Quarter 2020 Financial Results Conference Call and Webcast on October 29, 2020 GlobeNewswire Inc. - 10/27/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2020 7:14:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2020 7:13:15 AM
Lexicon Pharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce Outstanding Indebtedness GlobeNewswire Inc. - 9/23/2020 6:43:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/11/2020 4:12:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/8/2020 5:03:21 PM
Lexicon Pharmaceuticals Completes the Sale of XERMELO to TerSera Therapeutics GlobeNewswire Inc. - 9/8/2020 4:05:10 PM
Lexicon Pharmaceuticals Announces Commencement of Patient Dosing in RELIEF-DPN-1 Phase 2 Clinical Study of LX9211 in Patients... GlobeNewswire Inc. - 9/4/2020 8:00:10 AM
Lexicon Pharmaceuticals to Participate in the Citi 15ᵗʰ Annual BioPharma Virtual Conference and the Wells Fargo 2020 Virtu... GlobeNewswire Inc. - 9/3/2020 6:00:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 6:00:51 AM
GTCR and TerSera Therapeutics Announce Acquisition of Xermelo PR Newswire (US) - 8/3/2020 7:25:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2020 7:19:01 AM
Lexicon Realigns Business Around Research and Development Assets, with Focus on Phase 2 LX9211 Neuropathic Pain Program GlobeNewswire Inc. - 7/30/2020 7:15:10 AM
Lexicon Pharmaceuticals Enters Into Agreement With TerSera Therapeutics for the Sale of XERMELO GlobeNewswire Inc. - 7/30/2020 7:10:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2020 7:05:27 AM
Lexicon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides a Business Update GlobeNewswire Inc. - 7/30/2020 7:00:10 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 7/29/2020 5:08:32 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/29/2020 4:57:55 PM
Lexicon Pharmaceuticals to Host Second Quarter 2020 Financial Results Conference Call and Webcast on July 30, 2020 GlobeNewswire Inc. - 7/23/2020 7:00:10 AM
Lexicon Pharmaceuticals Announces Topline Phase 3 Data From Four Phase 3 Sotagliflozin Studies in Type 2 Diabetes GlobeNewswire Inc. - 7/21/2020 7:00:10 AM
BooDog   Friday, 07/31/20 11:03:10 AM
Re: PENNIEStoSTACKS post# 609
Post # of 641 
Shorts wanted to fill the gap is what I'm thinking. Mission accomplished for the most part.

LXRX


Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?

"We hope not." Richard Dennis
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences